Skip to main content
. 2010 Oct 22;3(3):289. doi: 10.4022/jafib.289

Table 3. Incidence of Endpoints During the Study.

A p<0.05 was considered statistically significant

Outcome Low-dose group(n = 57) High-dose group(n = 43) p value
Atrial Fibrillation 5/55(9%) 0/41(0%) <0.05
New Atrial Fibrillation 1/49(2%) 0/37(0%) N.S.
Recurrent Atrial Fibrillation 4/6(67%) 0/4(0%) <0.05